Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Merck & Co. reports on L-163689

Aug. 30, 1996

Aldose reductase/5-lipoxygenase inhibitors reported by Tsumura

Aug. 30, 1996

Aldose reductase inhibitors from Terumo

Aug. 30, 1996

Sankyo reports novel hypoglycemic agents

Aug. 30, 1996

Positive efficacy/safety profile for maximal-dose sulfonylurea therapy reported

Aug. 30, 1996

Beta3-adrenoceptor agonists described by Dainippon

Aug. 30, 1996

Cangene and Cheil Jedang sign Leucotropin agreement

Aug. 30, 1996

CCK antagonists from Warner-Lambert

Aug. 30, 1996

NGD-95-1 demonstrates safety in phase I

Aug. 30, 1996

More squalene synthase inhibitors from Pfizer

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026